science wire

« BACK

Pharmacology



Results 151 - 200 of 2718.


Health - Pharmacology - 10.09.2021
Majority of older adults say health care workers should have to get COVID-19 vaccine
Poll taken before new federal policy announced shows strong support across the board among people age 50 to 80, with some exceptions A new poll finds strong support among older Americans for requiring health care workers to get vaccinated against COVID-19.

Health - Pharmacology - 09.09.2021
Bacteria blasting cancer treatment shows promise
Bacteria blasting cancer treatment shows promise
A low-cost, non-toxic cancer treatment has been developed by researchers at The Australian National University (ANU).   The treatment uses dead bacteria to help kick-start the immune system and shrin

Campus - Pharmacology - 08.09.2021
Daily marijuana use among US college students reaches new 40-year high
Daily marijuana use among US college students reaches new 40-year high
National study also shows increases in hallucinogen use, reaching highest level among college students since early 1980s Daily marijuana use increased in 2020 to an all-time high among U.S&per

Health - Pharmacology - 07.09.2021
Planned surgery in independent sector linked to shorter hospital stays and fewer readmissions than in NHS
Planned surgery in an independent sector hospital in England, and funded by the NHS, is associated with shorter lengths of stay and lower readmission rates than the same treatment in NHS hospitals, finds research led by the University of Birmingham.

Health - Pharmacology - 01.09.2021
’No need to panic’ about viral variant found in South Africa
Scientists in South Africa have discovered a new viral variant of SARS-CoV-2, the virus that causes COVID-19.

Health - Pharmacology - 01.09.2021
Dog vaccination essential for preventing rabies spread to humans and animals
A coordinated and sustained programme of dog vaccination against rabies, is effective in preventing transmission of the deadly virus to humans and among animals, and remains key to rabies elimination. New research, led by the University of Glasgow in collaboration with Ifakara Health Institute and Imperial College London, published today in Applied Ecology, found that rabies incidence in both humans and domestic dogs decreased during a period of sustained dog vaccination in southeast Tanzania, despite incidences of ongoing wildlife rabies infections.

Health - Pharmacology - 31.08.2021
Human Mini-Lungs Grown in Lab Dishes are Closest Yet to Real Thing
Realistic mini-lungs, grown in lab dishes using adult stem cells, feature all cell types that make up the human organ, allowing for "Phase 0" testing of new treatments for respiratory diseases, including COVID-19 Since the COVID-19 pandemic reached the United States in early 2020, scientists have struggled to find laboratory models of SARS-CoV-2 infection, the respiratory virus that causes COVID-19.

Pharmacology - Health - 30.08.2021
Novartis Leqvio * (inclisiran) analyses show effective and sustained LDL-C reduction in two sub-populations of patients with ASCVD
Separate post hoc analyses of pooled Phase III ORION-9, -10 and -11 data show twice-yearly** Leqvio (inclisiran) consistently reduced low-density lipoprotein cholesterol (LDL-C) in patients with athe

Health - Pharmacology - 26.08.2021
Global COVID-19 surgery study scoops scientific world record
Global COVID-19 surgery study scoops scientific world record
A study led by University of Birmingham experts has been awarded the Guinness World Records title for the world's largest scientific collaboration - involving over 140,000 patients in 116 countries.

Health - Pharmacology - 26.08.2021
Woman who has lived with 30 year cough receives world-first dose of potential new treatment
A 70-year-old woman, forced to live with cough since her 40s, is 'excited' to be the first person in the world to receive a potential new cough treatment at the NIHR Manchester Clinical Research Facility (CRF) .

Health - Pharmacology - 26.08.2021

Health - Pharmacology - 25.08.2021
Tailoring Treatment of Patients with the Lung Disease COPD
Patients with COPD are treated with drugs to improve the breathing ability in combination with inhaled corticosteroids to reduce the risk of acute worsening of the lung conditions. But the balance between reduced exacerbations and increased adverse effects of the drugs depends on the dose and on patient characteristics.

Health - Pharmacology - 24.08.2021
What do we know about SARS-CoV-2 variants?
UChicago Board of Trustees' gift launches new $200 million commitment to undergraduate financial aid and educational access Prof. Kathleen Mullane discusses COVID-19 variants, and why vaccines

Health - Pharmacology - 24.08.2021
New study to test third COVID-19 vaccine for people with weakened immune systems
A new clinical trial led by the Universities of Birmingham and Glasgow has launched in the UK to determine whether a third dose of vaccine will improve the immune response for people who have weakened immune systems. The study, OCTAVE DUO, will offer people who are immunosuppressed or immunocompromised a Pfizer, Moderna or Novavax vaccine to determine whether this will give a stronger immune response than two doses.

Health - Pharmacology - 24.08.2021
Two Studies Seek to Go Beyond the GIST of Intestinal Tract Cancer
UC San Diego researchers identify the mutational drivers for gastrointestinal stroma tumors in the stomach and find a potential drug to treat a subset of GIST tumors afflicting the young Gastrointest

Pharmacology - Health - 24.08.2021
Novartis provides update on BELINDA study investigating Kymriah as second-line treatment in aggressive B-cell non-Hodgkin lymphoma
Phase III BELINDA study did not meet primary endpoint of event-free survival for patients with aggressive B-cell non-Hodgkin lymphoma who had primary refractory disease or who relapsed within 12 mont

Social Sciences - Pharmacology - 24.08.2021
How Adolescents Used Drugs During the COVID-19 Pandemic
Alcohol use declined, but use of nicotine and misuse of prescription drugs rose The advent of the COVID-19 pandemic, which began in earnest in the United States in early 2020, affected different demographic groups in different ways. According to a new study, among adolescents ages 10 to 14 in the U.S., the overall rate of drug use remained relatively stable in the first six months of the COVID-19 pandemic.

Career - Pharmacology - 20.08.2021

Pharmacology - Computer Science - 20.08.2021
Team Creates Software To Optimize Pharmaceutical Development
Carnegie Mellon University The development of a new medication is an incredibly complex process. From laboratory research, to testing for safety and efficacy, to setting up manufacturing and obtaining regulatory approval, the process can take up to a decade - and that's only for one pharmaceutical product.

Pharmacology - Health - 18.08.2021
Rheon Medical is revolutionizing the surgical treatment of glaucoma
EPFL spin-off Rheon Medical has developed the world's first adjustable glaucoma drainage system, which has already been used successfully in over 250 patients in Europe.

Health - Pharmacology - 18.08.2021
What you should know about COVID-19 booster shots and third vaccine doses
Assoc. Prof. Emily Landon clarifies the differences between third doses and booster shots Increasingly, research shows many people who have weakened immune systems haven't been able to receive full protection from their COVID-19 vaccines.

Health - Pharmacology - 12.08.2021
Ultrasound Remotely Triggers Immune Cells to Attack Tumors in Mice Without Toxic Side Effects
Bioengineers at the University of California San Diego have developed a cancer immunotherapy that pairs ultrasound with cancer-killing immune cells to destroy malignant tumors while sparing normal tissue.

Health - Pharmacology - 09.08.2021
Interview: Prof Francois Balloux - ’The pandemic has created a market for gloom and doom’
Francois Balloux (UCL Genetics Institute) discusses the risk of new variants, psychosomatic long Covid and when he expects the crisis to end.

Health - Pharmacology - 06.08.2021
Licensed drug could reduce SARS-CoV-2 infection by up to 70 per cent, reveals study
A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, reveals a study in the laboratory by an international collaboration of researchers. The research team, led by the University of Birmingham and Keele University in the UK and the San Raffaele Scientific Institute in Italy, has demonstrated that fenofibrate and its active form (fenofibric acid) can significantly reduce SARS-COV-2 infection in human cells in the laboratory.

Health - Pharmacology - 05.08.2021
Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester
Medicines Discovery Catapult (MDC) today announces the relaunch of radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) in Manchester.

Health - Pharmacology - 05.08.2021
Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Cambridge scientists have grown beating heart cells in the lab and shown how they are vulnerable to SARS-CoV-2 infection. In a study published in , they used this system to show that an experimental peptide drug called DX600 can prevent the virus entering the heart cells. Using stem cells, we've managed to create a model which, in many ways, behaves just like a heart does, beating in rhythm.

Health - Pharmacology - 05.08.2021
RECOVERY-RS trial finds continuous positive airway pressure (CPAP) reduces need for invasive ventilation in hospitalised COVID-19 patients
Landmark UK trial compared three commonly used respiratory interventions to establish which works best for COVID-19 patients with acute respiratory failure.

Health - Pharmacology - 04.08.2021
Artificial pancreas trialled for outpatients with type 2 diabetes for first time
Artificial pancreas trialled for outpatients with type 2 diabetes for first time
An artificial pancreas could soon help those people living with type 2 diabetes who also require kidney dialysis.

Health - Pharmacology - 04.08.2021
Women voice frustration over current care for recurrent urinary tract infections
Women with frequent urinary tract infections say they're unhappy with what they perceive as their doctors' overuse of antibiotics and with the limited treatment options available to them, according to a study led by researchers from UCLA and Cedars-Sinai. The research, recently published in the Journal of Urology, highlights the need for physicians to do a better job finding out why patients get recurrent UTIs, to develop strategies to prevent them and to avoid the unnecessary use of antibiotics, which over time can lead to resistance to the medication.

Health - Pharmacology - 04.08.2021
Q&A: Realism on Achieving Herd Immunity with Dr. Chip Schooley
"When will we get 'back to normal''" is a question looming on many Americans' minds. The answer largely depends on the country's ability to substantially ramp up immunity to SARS CoV-2 .

Pharmacology - Health - 03.08.2021
World-first UK trial to assess whether cannabis-based drug could extend life for thousands with aggressive brain tumours
The University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.

Health - Pharmacology - 03.08.2021
Patients who miss multiple GP appointments stay missing from healthcare
Patients who miss multiple GP appointments stay missing from healthcare
Research tracking people across the health service shows that patients who miss multiple GP appointments are not seeking help from Emergency Departments.    Last updated on Wednesday 11 August 2021 R